<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38540194</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Pituitary-Adrenal Axis and Peripheral Immune Cell Profile in Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">581</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12030581</ELocationID><Abstract><AbstractText>In Long COVID, dysfunction in the pituitary-adrenal axis and alterations in immune cells and inflammatory status are warned against. We performed a prospective study in a cohort of 42 patients who suffered COVID-19 at least 6 months before attending the Long COVID unit at Althaia Hospital. Based on Post-COVID Functional Status, 29 patients were diagnosed with Long COVID, while 13 were deemed as recovered. The hormones of the pituitary-adrenal axis, adrenocorticotropin stimulation test, and immune cell profiles and inflammatory markers were examined. Patients with Long COVID had significantly lower EuroQol and higher mMRC scores compared to the recovered individuals. Their symptoms included fatigue, myalgia, arthralgia, persistent coughing, a persistent sore throat, dyspnoea, a lack of concentration, and anxiety. We observed the physiological levels of cortisol and adrenocorticotropin in individuals with or without Long COVID. The results of the adrenocorticotropin stimulation test were similar between both groups. The absolute number of neutrophils was lower in the Long COVID patients compared to recovered individuals (<i>p</i> &lt; 0.05). The total count of B lymphocytes remained consistent, but Long COVID patients had a higher percentage of mature B cells compared to recovered participants (<i>p</i> &lt; 0.05) and exhibited a higher percentage of circulating resident memory CD8+ T cells (<i>p</i> &lt; 0.05) and Treg-expressing exonucleases (<i>p</i> &lt; 0.05). Our findings did not identify adrenal dysfunction related to Long COVID, nor an association between adrenal function and clinical symptoms. The data indicated a dysregulation in certain immune cells, pointing to immune activation. No overt hyperinflammation was observed in the Long COVID group.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alijotas-Reig</LastName><ForeName>Jaume</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Research Unit, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron (HUVH), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Universitat Aut&#xf2;noma de Barcelona (UAB), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anunciacion-Llunell</LastName><ForeName>Ariadna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Research Unit, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esteve-Valverde</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1403-8419</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Universitat Aut&#xf2;noma de Barcelona (UAB), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Universitari Parc Taul&#xed;, 08208 Sabadell, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales-P&#xe9;rez</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Systemic Autoimmune Disease Unit, Internal Medicine Department, Althaia Healthcare University Network of Manresa, 08243 Manresa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivero-Santana</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Systemic Autoimmune Disease Unit, Internal Medicine Department, Althaia Healthcare University Network of Manresa, 08243 Manresa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trap&#xe9;</LastName><ForeName>Jaume</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory Medicine, Althaia Healthcare University Network of Manresa, 08243 Manresa, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tissue Repair and Regeneration Laboratory (TR2Lab), Institut de Recerca i Innovaci&#xf3; en Ci&#xe8;ncies de la Vida i de la Salut a la Catalunya Central (IrisCC), 08500 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Garc&#xed;a</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2544-8365</Identifier><AffiliationInfo><Affiliation>Laboratory Medicine, Althaia Healthcare University Network of Manresa, 08243 Manresa, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tissue Repair and Regeneration Laboratory (TR2Lab), Institut de Recerca i Innovaci&#xf3; en Ci&#xe8;ncies de la Vida i de la Salut a la Catalunya Central (IrisCC), 08500 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz</LastName><ForeName>Domingo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Systemic Autoimmune Disease Unit, Internal Medicine Department, Althaia Healthcare University Network of Manresa, 08243 Manresa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques-Soares</LastName><ForeName>Joana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Research Unit, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron (HUVH), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Medicine, Universitat Aut&#xf2;noma de Barcelona (UAB), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miro-Mur</LastName><ForeName>Francesc</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3936-2693</Identifier><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Research Unit, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Synlab-JAR/2023</GrantID><Agency>Synlab Group (Barcelona)</Agency><Country/></Grant><Grant><GrantID>UAB-Gravida-JAR/2023</GrantID><Agency>Catedra UAB-Gravida de Medicina i Immunologia Reproductiva (Barcelona)</Agency><Country/></Grant><Grant><GrantID>SEMCC-JAR/2023</GrantID><Agency>Sociedad Espa&#xf1;ola de Medicina y Cirug&#xed;a Cosm&#xe9;tica (SEMCC, Barcelona)</Agency><Country/></Grant><Grant><GrantID>Althaia-JAR/2021</GrantID><Agency>Fundacio Althaia-Aig&#xfc;es de Manresa (Barcelona)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">adrenal insufficiency</Keyword><Keyword MajorTopicYN="N">cortisol</Keyword><Keyword MajorTopicYN="N">dyspnea</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">immune cells</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38540194</ArticleId><ArticleId IdType="pmc">PMC10968573</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12030581</ArticleId><ArticleId IdType="pii">biomedicines12030581</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 2023;29:2347&#x2013;2357. doi: 10.1038/s41591-023-02521-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansey C.M., Louie M., Loeb M., Gold W.L., Muller M.P., de Jager J., Cameron J.I., Tomlinson G., Mazzulli T., Walmsley S.L., et al. One-Year Outcomes and Health Care Utilization in Survivors of Severe Acute Respiratory Syndrome. Arch. Intern. Med. 2007;167:1312&#x2013;1320. doi: 10.1001/archinte.167.12.1312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.12.1312</ArticleId><ArticleId IdType="pubmed">17592106</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortinovis M., Perico N., Remuzzi G. Long-term follow-up of recovered patients with COVID-19. Lancet. 2021;397:173&#x2013;175. doi: 10.1016/S0140-6736(21)00039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00039-8</ArticleId><ArticleId IdType="pmc">PMC7833833</ArticleId><ArticleId IdType="pubmed">33428868</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient-Led Research Collaborative  Report: What Does COVID-19 Recovery Actually Look Like?&#x2014;Patient Led Research Collaborative 2020.  [(accessed on 30 November 2023)].  Available online:  https://patientresearchcovid19.com/research/report-1/</Citation></Reference><Reference><Citation>Wang Z., Yang L. Post-acute Sequelae of SARS-CoV-2 Infection: A Neglected Public Health Issue. Front. Public Health. 2022;10:908757. doi: 10.3389/fpubh.2022.908757.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.908757</ArticleId><ArticleId IdType="pmc">PMC9247346</ArticleId><ArticleId IdType="pubmed">35784200</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The lasting misery of coronavirus long-haulers. Nature. 2020;585:339&#x2013;341. doi: 10.1038/d41586-020-02598-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02598-6</ArticleId><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>Belluck P. Covid Survivors with Long-Term Symptoms Need Urgent Attention, Experts Say. N Y Times 2021.  [(accessed on 21 January 2021)].  Available online:  https://www.nytimes.com/2021/01/08/health/Covid-survivors-longterm.html.</Citation></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D.H., Roy D.J., Gu B.J., Hassett L.C., McCoy R.G. Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A State-of-the-Art Review. JACC Basic Transl. Sci. 2021;6:796&#x2013;811. doi: 10.1016/j.jacbts.2021.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.07.002</ArticleId><ArticleId IdType="pmc">PMC8442719</ArticleId><ArticleId IdType="pubmed">34541421</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker A.M., Brigham E., Connolly B., McPeake J., Agranovich A.V., Kenes M.T., Casey K., Reynolds C., Schmidt K.F.R., Kim S.Y., et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: A multidisciplinary model of care. Lancet Respir. Med. 2021;9:1328&#x2013;1341. doi: 10.1016/S2213-2600(21)00385-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00385-4</ArticleId><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network. Morb. Mortal. Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergwerk M., Gonen T., Lustig Y., Amit S., Lipsitch M., Cohen C., Mandelboim M., Levin E.G., Rubin C., Indenbaum V., et al. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N. Engl. J. Med. 2021;385:1474&#x2013;1484. doi: 10.1056/NEJMoa2109072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109072</ArticleId><ArticleId IdType="pmc">PMC8362591</ArticleId><ArticleId IdType="pubmed">34320281</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Capdevila Pujol J., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Association of Treatment with Nirmatrelvir and the Risk of Post&#x2013;COVID-19 Condition. JAMA Intern. Med. 2023;183:554&#x2013;564. doi: 10.1001/jamainternmed.2023.0743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0743</ArticleId><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Agergaard J., Gunst J.D., Schi&#xf8;ttz-Christensen B., &#xd8;stergaard L., Wejse C. Long-term prognosis at 1.5 years after infection with wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron variants. Int. J. Infect. Dis. 2023;137:126&#x2013;133. doi: 10.1016/j.ijid.2023.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.10.022</ArticleId><ArticleId IdType="pubmed">37907167</ArticleId></ArticleIdList></Reference><Reference><Citation>Bildirici Y., Metintas S., Ucan A., Ak G., Guvenc S.E., Metintas M. Post-COVID-19 syndrome in a cohort of hospitalized COVID-19 patients. Eur. Rev. Med. Pharmacol. Sci. 2023;27:8291&#x2013;8300. doi: 10.26355/eurrev_202309_33589.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202309_33589</ArticleId><ArticleId IdType="pubmed">37750657</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Huang C., Gu X., Wang Y., Li X., Liu M., Wang Q., Xu J., Wang Y., Dai H., et al. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: A longitudinal cohort study. Lancet Respir. Med. 2023;12:55&#x2013;66. doi: 10.1016/S2213-2600(23)00387-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00387-9</ArticleId><ArticleId IdType="pubmed">38000376</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., H&#xe4;llqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. &#x2018;The long tail of COVID-19&#x2032;&#x2014;The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2020;9:1349. doi: 10.12688/f1000research.27287.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.1</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J.R., Dhodapkar R.M., Lu P., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic dysfunction in &#x2018;long COVID&#x2019;: Rationale, physiology and management strategies. Clin. Med. 2021;21:e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., Devason A.S., Umana I.C., Cox T.O., Dohnalov&#xe1; L., Litichevskiy L., Perla J., Lundgren P., Etwebi Z., Izzo L.T., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867.e20. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini D.M., Brunjes D.L., Lala A., Trivieri M.G., Contreras J.P., Natelson B.H. Use of Cardiopulmonary Stress Testing for Patients with Unexplained Dyspnea Post&amp;ndash; Coronavirus Disease. JACC Heart Fail. 2021;9:927&#x2013;937. doi: 10.1016/j.jchf.2021.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri J.W., Dybas J.M., Fazelinia H., Kim M.S., Frere J., Zhang Y., Albrecht Y.S., Murdock D.G., Angelin A., Singh L.N., et al. Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Sci. Transl. Med. 2023;15:eabq1533. doi: 10.1126/scitranslmed.abq1533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq1533</ArticleId><ArticleId IdType="pubmed">37556555</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano A.H., Maya J., Giloteaux L., Peterson D.L., Maynard M., Gottschalk C.G., Hanson M.R. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J. Clin. Investig. 2020;130:1491&#x2013;1505. doi: 10.1172/JCI132185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132185</ArticleId><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong J.-G., Ravishankar A., Sharma S., Parkhurst C.N., Grassmann S.A., Wingert C.K., Laurent P., Ma S., Paddock L., Miranda I.C., et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell. 2023;186:3882&#x2013;3902.e24. doi: 10.1016/j.cell.2023.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.07.019</ArticleId><ArticleId IdType="pmc">PMC10638861</ArticleId><ArticleId IdType="pubmed">37597510</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Boon G.J., Barco S., Endres M., Geelhoed J.M., Knauss S., Rezek S.A., Spruit M.A., Vehreschild J., Siegerink B. The Post-COVID-19 Functional Status scale: A tool to measure functional status over time after COVID-19. Eur. Respir. J. 2020;56:2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M., Badia X., Berra S. EuroQol-5D: A simple alternative for measuring health-related quality of life in primary care. Aten Primaria. 2001;28:425&#x2013;430. doi: 10.1016/S0212-6567(01)70406-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0212-6567(01)70406-4</ArticleId><ArticleId IdType="pmc">PMC7684037</ArticleId><ArticleId IdType="pubmed">11602124</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO COVID-19 Dashboard  Spain: WHO Coronavirus Disease (COVID-19) Dashboard with Vaccination Data 2020.  [(accessed on 30 November 2023)].  Available online:  https://covid19.who.int.</Citation></Reference><Reference><Citation>Troyano-Hern&#xe1;ez P., Reinosa R., Holgu&#xed;n A. Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins. Int. J. Mol. Sci. 2022;23:6394. doi: 10.3390/ijms23126394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23126394</ArticleId><ArticleId IdType="pmc">PMC9223475</ArticleId><ArticleId IdType="pubmed">35742840</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated with Post-acute Coronavirus Disease 2019 Sequelae. Clin. Infect. Dis. 2022;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccato F., Selmin E., Antonelli G., Barbot M., Daniele A., Boscaro M., Plebani M., Scaroni C. Low-dose short synacthen test with salivary cortisol in patients with suspected central adrenal insufficiency. Endocr. Connect. 2021;10:1189&#x2013;1199. doi: 10.1530/EC-21-0404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-21-0404</ArticleId><ArticleId IdType="pmc">PMC8494418</ArticleId><ArticleId IdType="pubmed">34424852</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaler L.M., Blevins L.S. The Low Dose (1-&#xb5;g) Adrenocorticotropin Stimulation Test in the Evaluation of Patients with Suspected Central Adrenal Insufficiency. J. Clin. Endocrinol. Metab. 1998;83:2726&#x2013;2729. doi: 10.1210/jcem.83.8.5039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.83.8.5039</ArticleId><ArticleId IdType="pubmed">9709938</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi P.G., Shah N.S., Khandelwal A.G., Chauhan P., Menon P.S. Evaluation of low dose ACTH stimulation test in suspected secondary adrenocortical insufficiency. J. Postgrad. Med. 2002;48:280&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">12571383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lazarus K., Papadopoulou D., Prabhudev H., Tan T., Meeran K., Choudhury S. Optimising prednisolone or prednisone replacement in adrenal insufficiency. Endocr. Connect. 2023;12:e230097. doi: 10.1530/EC-23-0097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-23-0097</ArticleId><ArticleId IdType="pmc">PMC10388668</ArticleId><ArticleId IdType="pubmed">37289726</ArticleId></ArticleIdList></Reference><Reference><Citation>Alijotas-Reig J., Anunciaci&#xf3;n-Llunell A., Morales-P&#xe9;rez S., Trap&#xe9; J., Esteve-Valverde E., Miro-Mur F. Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity. Biomedicines. 2023;11:2301. doi: 10.3390/biomedicines11082301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11082301</ArticleId><ArticleId IdType="pmc">PMC10452204</ArticleId><ArticleId IdType="pubmed">37626797</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.-A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>